Technology & Innovation

Enzyme Chemistry: GOx vs. GDH

The choice of enzyme in diabetic test strips—Glucose Oxidase (GOx) versus Glucose Dehydrogenase (GDH)—represents a trade-off between specificity and environmental stability.

GOx is the traditional standard, offering high specificity for glucose with no cross-reactivity to other sugars. However, it is susceptible to the "Oxygen Effect," where variations in blood oxygen levels (e.g., in COPD patients or at high altitudes) can skew results.

GDH enzymes solve the oxygen problem, allowing for accurate testing in venous and arterial blood. However, early iterations using the PQQ cofactor (GDH-PQQ) caused fatal errors by cross-reacting with non-glucose sugars like maltose (common in dialysis patients). This led to a massive industry shift toward GDH-FAD, which combines the oxygen-independence of GDH with the glucose-specificity of GOx, effectively mitigating the risks associated with both oxygen tension and maltose interference.

1 min read
Beginner
3 glossary terms
1 citations

Enzyme Chemistry: GOx vs. GDH

Diabetic test strips rely on enzymes for glucose detection.

Glucose Oxidase (GOx) and Glucose Dehydrogenase (GDH) are the two primary options.

GOx offers high specificity for glucose, with no cross-reactivity to other sugars [1].

However, it suffers from the Oxygen Effect, where blood oxygen levels impact results [2].

GDH enzymes overcome this limitation, enabling accurate testing in various blood types.

Early GDH-PQQ versions were prone to fatal errors due to cross-reactivity with non-glucose sugars like maltose [3].

The industry has shifted to GDH-FAD, which combines oxygen independence with glucose specificity, reducing risks associated with oxygen tension and maltose interference [4].

References

  1. FDA Public Health Notification: Potentially Fatal Errors with GDH-PQQ Glucose Monitoring TechnologySource

Was this article helpful?

Explore More Topics

Continue your research with related categories